Infection Clinical Trial
Official title:
Developing and Maintaining a Central Venous Catheter Registry
It has been estimated that 90% of bloodstream infections associated with catheters, are due to CVCs, and that 500 to 4,000 patients in the United States die annually due to these bloodstream infections. The risk of central line associated bloodstream infections is typically expressed as the number of line infections per 1000 catheter days. This study's goal is to develop a uniform CL protocol, updated practice guidelines based on current evidence, and a standard procedural checklist based on CL care bundles recommended by the Institute for Healthcare Improvement. A secondary goal is to create a CL registry to capture and store data relevant to each CL placed throughout the institution. This registry will provide a wealth of data on CL insertions and complications that may be used as a valuable source of information for quality assurance, performance improvement, and research. With the knowledge and information obtained through this registry, educational offerings can be created, and a standardized institutional process for CL insertion can be developed.
The use of central venous catheters(CVCs) has increased in both the inpatient and outpatient
settings.CVCs disturb skin integrity and create vulnerability for bacterial and fungal
infections. It has been estimated that 90% of bloodstream infections associated with
catheters, are due to CVCs, and that 500 to 4,000 patients in the United States die annually
due to these bloodstream infections (Mermel, 2000). The risk of central line (CL)associated
bloodstream infections (CLAB) is typically expressed as the number of line infections per
1000 catheter days.A recent study demonstrated that following a set of standardized
procedures can reduce the mean CLAB rate from 7.7 per 1000 catheter days to 1.4 (Pronovost
et al., 2006).In an effort to decrease hospital acquired bloodstream infections and
complications resulting from CVCs, an initiative to standardize and track CL placement
throughout the institution is proposed. A uniform CL protocol will be developed;practice
guidelines will be updated based on current evidence, and a standard procedural checklist
will be developed based on CL care bundles recommended by the Institute for Healthcare
Improvement (IHI)(5 Million Lives, 2007).Generally,a care bundle is a series of best
practices that each enhances care when applied individually, but considerably improves care
when implemented together.The CL care bundle includes hand hygiene, barrier precautions,
chlorhexidine skin antisepsis, optimal site selection, and daily consideration of line
necessity, with timely removal of unnecessary lines(5 Million Lives, 2007).Another goal of
this initiative is to create a CL registry to capture and store data relevant to each CL
placed throughout the institution.This registry will provide a wealth of data on CL
insertions and complications which may be used as a valuable source of information for
quality assurance, performance improvement, and research.Finally,with the knowledge and
information obtained through this registry, educational offerings can be created, and a
standardized institutional process for CL insertion can be developed.
Objective: 1.To capture information on each CL insertion throughout the institution.2.To
capture and track the amount of days a patient has a CL in place.3.To capture and track CL
infectious complications.4.To capture and track mechanical complications.5.To capture
data,which may be used as a valuable source of information for quality assurance,
performance improvement, education, and research.
;
Observational Model: Cohort, Time Perspective: Retrospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04529421 -
Assocation Between In-person Instruction and COVID-19 Risk
|
||
| Recruiting |
NCT04081792 -
Optimal Antibiotics for Operated Diabetic Foot Infections
|
N/A | |
| Completed |
NCT04332861 -
Evaluation of Infection in Obstructing Urolithiasis
|
||
| Recruiting |
NCT04674657 -
Does Extra-Corporeal Membrane Oxygenation Alter Antiinfectives Therapy Pharmacokinetics in Critically Ill Patients
|
||
| Enrolling by invitation |
NCT05052203 -
Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
|
||
| Recruiting |
NCT00342589 -
New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis Pneumonia
|
||
| Completed |
NCT03295825 -
Heparin Binding Protein in Early Sepsis Diagnosis
|
N/A | |
| Completed |
NCT03296423 -
Bacillus Calmette-guérin Vaccination to Prevent Infections of the Elderly
|
Phase 4 | |
| Withdrawn |
NCT04217252 -
Clinical Application of High-throughput Sequencing Technology for the Diagnosis of Patients With Severe Infection
|
N/A | |
| Recruiting |
NCT02899143 -
Short-course Antimicrobial Therapy in Sepsis
|
Phase 2 | |
| Recruiting |
NCT02905552 -
Myelodysplasic Syndromes and Risk Factors for Infection
|
N/A | |
| Withdrawn |
NCT02904434 -
Gastrointestinal Implications of Voriconazole Exposure
|
||
| Active, not recruiting |
NCT02768454 -
Antimicrobials Stewardship by Pharmacist
|
N/A | |
| Completed |
NCT02219776 -
Decreasing Infection In Arthroscopic Shoulder Surgery
|
N/A | |
| Completed |
NCT02210169 -
RCT of Continuous Versus Intermittent Infusion of Vancomycin in Neonates
|
N/A | |
| Recruiting |
NCT02098226 -
Evaluation of MALDI Biotyper CA System for Detection of Gram- and Gram+ Bacteria and Yeasts
|
N/A | |
| Completed |
NCT01846832 -
A Study of TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV Infection
|
Phase 3 | |
| Terminated |
NCT01441206 -
Safety and Pharmacokinetics of Single and Multiple Dose Rifampin in Infants
|
Phase 1 | |
| Completed |
NCT01434797 -
Value of PET/CT Imaging in the Diagnosis of Permanent Central Venous Catheters Infection
|
||
| Completed |
NCT01159834 -
Human Papillomavirus (HPV) Vaccination in Barretos (Pio XII Foundation - Barretos Cancer Hospital)
|
N/A |